Oracle’s shift to AI infrastructure, major contracts, and rapid cloud growth position it for strong future growth. Read here ...

More than one in five pupils at primary and post-primary level missed over 20 days of school in the last school year, ...

Over 7 million Americans are living with the progressive and debilitating cognitive impairments caused by Alzheimer’s disease ...

Enanta Pharmaceuticals remains a Buy as zelicapavir shows promise in RSV trials; strong financials support growth. Read why ENTA stock remains a Buy.

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...

Niche.com, an education research platform, compiles the rankings annually based on data from the Department of Education, ...

As health-care workers around the world will attest, infections are extremely common in children in primary care and ...

Nine of the ten local authorities that have experienced the largest drops in primary school pupil numbers are in London, ...

Organogenesis Holdings Inc. (NASDAQ: ORGO) shared topline data on Thursday from the second Phase 3 randomized controlled ...

Qure N.V. (NASDAQ:QURE) on Wednesday released topline data from the pivotal Phase 1/2 study of AMT-130 for Huntington’s ...

Though candidates have been running in high-profile races all summer, the decision by several elected leaders shape ...

OCREVUS subcutaneous maintains consistent benefit-risk profile after two years New late-breaking data confirms OCREVUS significantly reduces disability progression in adults with advanced PPMSOne-year ...